These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2715790)

  • 1. Molecular mechanics calculations on deaminooxytocin and on deamino-arginine-vasopressin and its analogues.
    Liwo A; Tempczyk A; Grzonka Z
    J Comput Aided Mol Des; 1989 Jan; 2(4):281-309. PubMed ID: 2715790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the conformational space of oxytocin and arginine-vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methods.
    Liwo A; Tempczyk A; Ołdziej S; Shenderovich MD; Hruby VJ; Talluri S; Ciarkowski J; Kasprzykowski F; Lankiewicz L; Grzonka Z
    Biopolymers; 1996 Feb; 38(2):157-75. PubMed ID: 8589250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical studies of the mechanism of the action of the neurohypophyseal hormones. I. Molecular electrostatic potential (MEP) and molecular electrostatic field (MEF) maps of some vasopressin analogues.
    Liwo A; Tempczyk A; Grzonka Z
    J Comput Aided Mol Des; 1989 Sep; 3(3):261-84. PubMed ID: 2585002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical conformational analysis of three vasopressin antagonists with a modified cyclohexyl ring in the first thioacid residue.
    Kaźmierkiewicz R; Liwo A; Lammek B
    Int J Pept Protein Res; 1995 May; 45(5):451-8. PubMed ID: 7591484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
    Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B
    J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational analysis of [Cpp1, Sar7, Arg8] vasopressin by 1H-NMR spectroscopy and molecular mechanics calculations.
    Shenderovich MD; Kasprzykowski F; Liwo A; Sekacis I; Saulitis J; Nikiforovich GV
    Int J Pept Protein Res; 1991 Dec; 38(6):528-38. PubMed ID: 1819587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of vasopressin, oxytocin and their analogues [Mpa1, D-Arg8]-vasopressin (dDAVP) and [Mpa1, D-Tyr(Et)2, Thr4, Orn8]-oxytocin (antocin) in human kidney and liver homogenates.
    Fjellestad-Paulsen A; Lundin S
    Regul Pept; 1996 Nov; 67(1):27-32. PubMed ID: 8952002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical conformational analysis of six arginine vasopressin analogs with the L-naphthylalanine in position 3.
    Slusarz R; Kaźmierkiewicz R; Lammek B
    J Pept Res; 2000 Dec; 56(6):352-9. PubMed ID: 11152294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational aspects of differences in requirements for oxytocin and vasopressin receptors.
    Oldziej S; Ciarkowski J; Liwo A; Shenderovich MD; Grzonka Z
    J Recept Signal Transduct Res; 1995; 15(1-4):703-13. PubMed ID: 8903974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
    Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and quantification of nonapeptide binding sites in the kidney of Xenopus laevis: evidence for the existence of two different nonapeptide receptors.
    Kloas W; Hanke W
    Gen Comp Endocrinol; 1992 Jan; 85(1):71-8. PubMed ID: 1563620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular dichroism studies of some arginine-vasopressin analogues.
    Grzonka Z; Gwizdała E; Kasprzykowski F; Lankiewicz L
    Biophys Chem; 1988 Aug; 31(1-2):87-100. PubMed ID: 3233295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence study of neurohypophyseal hormones and their analogues. Distance distributions in a series of arginine-vasopressin analogues.
    Wiczk W; Lankiewicz L; Kasprzykowski F; Ołdziej S; Szmaciński H; Lakowicz JR; Grzonka Z
    Eur Biophys J; 1997; 26(2):183-93. PubMed ID: 9232846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micelle-bound conformations of neurohypophyseal hormone analogues modified with a Cα-disubstituted residue: NMR and molecular modelling studies.
    Sikorska E; Kwiatkowska A
    J Biomol Struct Dyn; 2013; 31(7):748-64. PubMed ID: 22908889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of four oxytocin analogues to myometrial oxytocin and arginine-vasopressin binding sites in pregnant women.
    Rydén G; Andersson RG; Berg G; Karlsson SG; Oscarsson Y
    Gynecol Obstet Invest; 1990; 29(1):6-9. PubMed ID: 2161784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
    Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
    J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.